US Stock MarketDetailed Quotes
ATNF 180 Life Sciences
- 1.870
- -0.130-6.50%
Close May 6 16:00 ET
- 1.950
- +0.080+4.28%
Post 19:46 ET
1.71MMarket Cap-35P/E (TTM)
1.980High1.860Low9.29KVolume1.920Open2.000Pre Close17.77KTurnover1.12%Turnover RatioLossP/E (Static)916.59KShares27.93052wk High-13.45P/B1.55MFloat Cap1.33052wk Low--Dividend TTM828.95KShs Float4957.214Historical High--Div YieldTTM6.00%Amplitude1.330Historical Low1.912Avg Price1Lot Size
About 180 Life Sciences Company
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.
Company Profile
SymbolATNF
Company Name180 Life Sciences
Listing DateJun 27, 2017
Founded2016
CEODr. James N. Woody, M.D.,PhD
MarketNASDAQ
Employees4
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address3000 El Camino Real,Building 4,Suite 200
CityPalo Alto
ProvinceCalifornia
CountryUnited States of America
Zip Code94306
Phone1-650-507-0669
Company Executives
- Name
- Position
- Salary
- Dr. James N. Woody, M.D.,PhD
- Chief Executive Officer and Director
- 463.50K
- Ozan Pamir
- Chief Financial Officer, Principal Accounting Officer and Secretary
- 309.00K
- Dr. Jonathan Rothbard, PhD
- Chief Scientific Officer
- 268.91K
- Dr. Lawrence J. Steinman, M.D.
- Executive Chairman of the Board
- 225.00K
- Blair Jordan
- Independent Director
- --
- Ryan L. Smith
- Independent Director
- --
- Omar Jimenez
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg